Alopecia includes male or female pattern baldness, alopecia areata, telogen effluvium, and anagen effluvium. Creams, oils, lotions, shampoos, and foam formulations of topical alopecia medications are meant to be applied to the scalp in alopecia treatment.
Increasing clinical trials in the treatment of alopecia are expected to fuel the growth of the Asia Pacific alopecia market over the forecast period. For instance, Concert Pharmaceuticals Inc. published new data analyses from its Phase 2 dose-ranging clinical trial of CTP 543 for the treatment of moderate-to-severe alopecia areata in June 2021.
Get Free Sample PDF Copy (Including Full TOC, List of Tables & Figures, Chart) @
Hair loss treatments’ side effects are likely to stifle market development. Some of the most common side effects include scalp inflammation, facial hair growth in women, sexual problems such as erectile dysfunction, and skin thinning.
The major factor driving the growth of the global Asia Pacific alopecia treatment market during the forecast period include the increasing prevalence of alopecia and consumer perception towards having good aesthetics.
Asia Pacific alopecia treatment market was valued at US$ 2,030.5 Mn in 2021 and is forecast to reach a value of US$ 3,214.8 Mn by 2029 at a CAGR of 6.8% between 2022 and 2029.
Asia Pacific alopecia treatment market is estimated to account for US$ 4,060.9 Mn in terms of value and is expected to reach US$ 6,427.7 Mn by the end of 2029
In terms of value, Alopecia Areata led the Asia Pacific alopecia care market in 2019, accounting for 65.8% of the market, followed by Alopecia Totalis and Alopecia Universalis. The segment’s growth is being aided by an increase in product launches for the treatment of alopecia and an increase in the incidence of alopecia areata.
Major players in the market are focused on conducting clinical trials for the treatment of alopecia. For instance, Pfizer, Inc. has five unique immunokinase inhibitors in late-stage clinical trials for the potential treatment of ten immune-mediated diseases as of June 2020, one of which is PF-06651600, an oral JAK3/TEC family kinase inhibitor in phase 3 clinical trial for the potential treatment of alopecia areata.
A new study has discovered a connection between androgenetic alopecia and the severity of COVID-19 disease. Antiandrogen therapy may be used as a treatment for COVID19 patients, according to a review published in May 2020 in Drug Development Research – Wiley Online Library titled “Androgen exposure gateway to COVID19 disease severity.”
The Industrial Chemicals (Notification and Assessment) Act of 1989 governs the notification and assessment of industrial chemicals. The National Industrial Chemicals Notification and Assessment Scheme is in charge of enforcing this law (NICNAS). The Act provides legal protection for the Cosmetics Standard 2007, which is backed up by the NICNAS Cosmetic Guidelines 2007.
Request PDF Brochure with Latest Insights @
Major players operating in the Asia Pacific alopecia market include Shiseido Co., Ltd., Concert Pharmaceuticals, Inc., Follica, Inc., REVIAN Inc., Incyte, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Johnson & Johnson, Inc., Pfizer, Inc., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cellmid Ltd., The Himalaya Drug Company, Taisho Pharmaceutical Holdings Co., Ltd., Histogen, Inc., and Zhangguang 101 Science & Technology Co., Ltd.
In January 2020, Concert Pharmaceuticals, Inc. received a patent from the U.S. Patent and Trademark Office for its investigational treatment for alopecia areata
In January 2020, REVIAN Inc. announced that final data from a randomized, double-blind study of the REVIAN RED hair growth system was presented at the 2020 Winter Clinical Dermatology Conference – Hawaii.
Reasons to buy this Asia Pacific Alopecia Treatment Market Report
◘ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Asia Pacific Alopecia Treatment Market
◘ Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Asia Pacific Alopecia Treatment Market
◘ Leading company profiles reveal details of key Asia Pacific Alopecia Treatment Market players emerging five operations and financial performance
◘ Add weight to presentations and pitches by understanding the future growth prospects of the emerging Asia Pacific Alopecia Treatment Market with five year historical forecasts
◘ Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Asia Pacific Alopecia Treatment Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Asia Pacific Alopecia Treatment Market are also given.
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Asia Pacific Alopecia Treatment Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Asia Pacific Alopecia Treatment Industry Impact
Chapter 2 Global Asia Pacific Alopecia Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Asia Pacific Alopecia Treatment (Volume and Value) by Type
2.3 Global Asia Pacific Alopecia Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Asia Pacific Alopecia Treatment Sales, Consumption, Export, Import by Regions
Chapter 5 North America Asia Pacific Alopecia Treatment Market Analysis
Chapter 6 East Asia Asia Pacific Alopecia Treatment Market Analysis
Chapter 7 Europe Asia Pacific Alopecia Treatment Market Analysis
Chapter 8 South Asia Asia Pacific Alopecia Treatment Market Analysis
Chapter 9 Southeast Asia Asia Pacific Alopecia Treatment Market Analysis
Chapter 10 Middle East Asia Pacific Alopecia Treatment Market Analysis
Chapter 11 Africa Asia Pacific Alopecia Treatment Market Analysis
Chapter 12 Oceania Asia Pacific Alopecia Treatment Market Analysis
Chapter 13 South America Asia Pacific Alopecia Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Asia Pacific Alopecia Treatment Business
Chapter 15 Global Asia Pacific Alopecia Treatment Market Forecast (2022-2028)
Chapter 16 Conclusions
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027